| No images? Click here  Friday 03.02.23 | Issue 189 WHO/ Francisco Guerrero Coronavirus disease (COVID-19) updates A virtual press briefing with simultaneous translation in all UN languages with the participation of the WHO Director-General is tentatively scheduled for next week. If confirmed, media advisory with dial-in details will be emailed in advance.  30 January - 7 February 2023 WHO’s 152nd Executive Board Meeting continuation The 152nd session of the Executive Board (EB) is taking place right now, from 30 January – 7 February 2023 and will continue tomorrow. The EB public proceedings continue to be webcast from this page. The Executive Board is composed of 34 technically qualified members elected for three-year terms. The main functions of the Board are to implement the decisions and policies of the Health Assembly, and to advise and generally facilitate its work. EB Documents, including the agenda, can be found here.  Monday, 6 February 2023 International Day of Zero Tolerance for Female Genital Mutilation (FGM) WHO will join partners in commemorating the International Day of Zero Tolerance for FGM. At least 200 million women and girls alive today have experienced FGM, which is an extreme form of discrimination, violates human rights, and causes serious health harms. WHO is working to raise awareness on the health risks associated with FGM and to tackle its increasing medicalization. Interviews are available with experts ahead of the Day. A factsheet on FGM can be found here  7-8 February 2023 Antimicrobial Resistance: meeting of the Global Leaders Group (GLG) Chaired by Her Excellency Mia Amor Mottley, Prime Minister of Barbados, the GLG is comprised of world leaders and experts from across sectors working together to accelerate political action on antimicrobial resistance (AMR) based on the One Health approach and achieve optimal and sustainable health outcomes for people, animals and ecosystems. The meeting will cover critical issues in the response to AMR, including financing, research and development, integrated surveillance, the role of the private sector, AMR and the environment, animal health and galvanizing political action to address AMR. The discussion will inform the process leading up to the 2024 UNGA high-level meeting on AMR at which the GLG will press for bold and specific commitments by member states. The sixth meeting of the GLG will take place in Barbados and will be their first in-person meeting. The GLG will formally welcome five new members during the meeting, with a diverse range of expertise, to strengthen the GLG’s efforts to galvanize political action to address AMR. Whilst this is a closed meeting, a formal meeting report, discussing meeting outcomes, will be available on the GLG website after the meeting.   Tuesday, 7 February 2023 Member States and relevant stakeholders briefing in preparation for INB4 The Bureau of the Intergovernmental Negotiating Body (INB) towards a convention, agreement or other international instrument on pandemic prevention, preparedness and response (the pandemic accord) is convening two briefings to Member States The purpose of these briefings is to inform Member States and relevant stakeholders on the development, approach and structure of the Zero Draft of the pandemic accord, as well as to provide a proposal from the Bureau regarding modalities for the fourth meeting of the INB (INB4) (scheduled to take place from 27 February to 3 March 2023) and INB5 (3 to 6 April 2023). The zero draft of the pandemic accord was shared with Member States and relevant stakeholders on 1 February, and published on the WHO website. These briefings will be publicly webcast on this page. Related links: Read more about the INB here  Wednesday, 8 February 2023 New Lancet Series on Breastfeeding On Wednesday, The Lancet will publish a special series containing critical new research on breastfeeding. Together, this three-paper series explores how breastfeeding is systematically undervalued by governments and public health, and exploited by the formula milk industry. Supported by WHO and partners, a live launch event will take place in London at the Royal Society of Medicine at 12:30 GMT/ 13:30 CET on 8 February. To register your interest in attending as press, please contact Laura Keenan, keenanl@who.int and Mary-Anne Land, landm@who.int. If you are not in the UK or able to attend in-person, you will also be able to follow our livestream here. Embargoed interviews, access to the papers and media materials are available ahead of the event. The event page can be accessed here More information on the marketing of formula milk can be found here WHO EPI-WIN webinar: Current COVID-19 situation and what's next for COVID-19 As we enter into the 4th year of the COVID-19 pandemic, we now have lifesaving tools and a better understanding of the virus dynamics. However, the virus continues to evolve with new variants reported. This webinar has an objective to provide an update on the current COVID-19 situation, the new variants, and discuss what it means for the pandemic and our lives. Information on registering and accessing the webinar can be found here. Speaker:  Sign up for our newsletters here. Check out the WHO series, Science in 5. Latest WHO Disease Outbreak News (DONs) here. Listen to Global Health Matters. Access WHO photos available for media use here.  WHO Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.
|
Friday, February 3, 2023
WHO | Week Ahead for media | 3 February 2023
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment